Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39976 | 0.73 | CYP2C9 (0.42) | CYP2C9HSD11B1EPHX1EPHX2 | |
| Lithium SCHEMBL5510213 | 0.71 | CYP2C9 (0.40) | CYP2C9HSD11B1EPHX1EPHX2 | |
| SCHEMBL13577591 | 0.69 | CYP2C9 (0.38) | CYP2C9HSD11B1EPHX1 | |
| SCHEMBL10584202 | 0.69 | CYP2C9 (0.38) | CYP2C9HSD11B1EPHX1 | |
| SCHEMBL3708629 | 0.69 | CYP2C9 (0.38) | CYP2C9HSD11B1EPHX1 | |
| SCHEMBL1238711 | 0.69 | CYP2C9 (0.38) | CYP2C9HSD11B1EPHX1CA1CA2 | |
| SCHEMBL251015 | 0.69 | CYP2C9 (0.38) | CYP2C9HSD11B1EPHX1 | |
| SCHEMBL1033337 | 0.67 | HSD11B1 (0.52) | CYP2C9HSD11B1EPHX1EPHX2HSD17B10 | |
| SCHEMBL5350579 | 0.67 | HSD11B1 (0.52) | CYP2C9HSD11B1EPHX1EPHX2HSD17B10 | |
| SCHEMBL7784801 | 0.66 | SMPD1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7371778-B2 | Spiro and dispiro 1,2,4-trioxolane antimalarials | MEDICINES FOR MALARIA VENTURE MMV (CH) | 2008-05-13 | — | — | US | disclosed |